InnoMedica Holding AG

26.11.2021

InnoMedica: Wichtige Fortschritte dank Kapitalerhöhung über 15 Millionen Franken (startupticker.ch)

09.04.2020

Smart answers to the corona virus (startupticker.ch)

28.11.2018

Innomedica-Medikament erreicht klinische Phase (startupticker.ch)

05.07.2018

Capital increase for InnoMedica (startupticker.ch)

28.12.2017

Innomedica: Erfolgreicher Abschluss der präklinischen Tests (startupticker.ch)

18.04.2017

InnoMedica bringt Krebsmedikament in die Schweizer Spitäler (startupticker.ch)

18.04.2017

InnoMedica bringt Krebsmedikament in die Schweizer Spitäler (startupticker.ch)

19.06.2016

Innomedica schliesst Finanzierungsrunde über drei Millionen Franken ab (startupticker.ch)

05.06.2015

1.3 Millionen Franken für InnoMedica (startupticker.ch)

16.01.2015

InnoMedica: Bewilligung zur Herstellung von Medikamenten (startupticker.ch)

24.04.2014

InnoMedica schliesst Finanzierungsrunde erfolgreich ab (startupticker.ch)

Ingenieurbüro Götsch AG

Research / Fulltime

InnoMedica, a dynamic nanotechnology company, is seeking a Scientist in Quality Control & Analytics for their research and production site in Marly, near Fribourg. The role focuses on performing GMP-compliant quality control testing for clinical trials and contributing to the development and validation of analytical methods for their pipeline of liposomal drug candidates in neurology and oncology. Ideal candidates hold a university degree in chemistry, pharmacy, or a related field, possess substantial experience with HPLC-based analytical methods, and demonstrate a strong sense of quality and analytical rigor. Experience in a GMP environment is preferred, and the position requires an independent, team-oriented professional capable of thriving in an innovative start-up atmosphere.

Login to apply